Lanxess Partners for Lewatit Resins in France

With immediate effect, Lanxess, a specialty chemicals company, will be distributing its Lewatit ion exchange resins and Bayoxide iron oxide adsorbers in France through Caldic,

EMA Recommends Approval for Uzpruvo Biosimilar

The CHMP's positive opinion for Uzpruvo is a historic moment as it is the first time the EMA has recommended a biosimilar to the Stelara reference product for authorization.

Training Mental Health Champions: Pearl Tiwari, Ambuja Foundation

Pearl Tiwari, director and CEO of Ambuja Foundation, suggests that training and equipping

Asian Coalition Hosts CME at Vardhman Mahavir Medical College

Recently, the Asian Coalition for Health Empowerment (ACHE) teamed up with Vardhman Mahavir

One Biosciences & AP-HP Collaborate on Rare Kidney Disease Study-HP

One Biosciences is a biotech company that utilizes the capabilities of single-cell analysis and artificial intelligence (A.I.)

Valneva's Ixchiq Chikungunya Vaccine Receives Us FDA Approval

Valneva SE, a company specializing in vaccines, has received approval from the US Food and Drug

Lipella Pharma's LP-310 Receives FDA Orphan Designation

Pittsburgh, Pennsylvania-based Lipella Pharmaceuticals Inc., a pharmaceutical company in the clinical stage focusing on serious diseases with significant unmet need

Alkem Labs Q2 Net Profit Soars 77% to Rs. 615 Crore

The 11,600 crore pharma giant has reported a significant increase in net profit for the second quarter ending in September 2023

WHO's Updated Covid-19 Treatment Guidelines

The World Health Organization (WHO) has revised its guidelines for Covid-19 therapeutics, providing updated recommendations for patients with non-severe Covid-19.

BCP's Strong Surge: 36% Profit Growth in Q2 2023

The company's net profit increased by 36% to Rs. 151 crore from Rs.1500 lakhs The Company’s total

© 2025 India Pharma Outlook. All Rights Reserved.